131 related articles for article (PubMed ID: 38733554)
1. Identification of NINJ1 as a novel prognostic predictor for retroperitoneal liposarcoma.
Zhao Y; Qin D; Li X; Wang T; Zhang T; Rao X; Min L; Wan Z; Luo C; Xiao M
Discov Oncol; 2024 May; 15(1):155. PubMed ID: 38733554
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study.
Li Y; Wu G; Zhang Y; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Zhong H; Fan D; Hong L
Front Oncol; 2022; 12():857827. PubMed ID: 35719991
[TBL] [Abstract][Full Text] [Related]
3. Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma.
Wang Z; Tao P; Fan P; Wang J; Rong T; Hou Y; Zhou Y; Lu W; Hong L; Ma L; Zhang Y; Tong H
Front Immunol; 2023; 14():1209396. PubMed ID: 37483592
[TBL] [Abstract][Full Text] [Related]
4. A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study.
Miao CL; Zhang LL; Tseng WW; Qiu FB; Lu WQ; Dai YG; Rao XS; Li WJ; Zhang GK; Chen J; Liu WQ; Chen XB; Xiao MM; Cha LC; Wang JY; Ren YB; Yang HY; Luo CH
Ann Transl Med; 2022 Jul; 10(14):785. PubMed ID: 35965811
[TBL] [Abstract][Full Text] [Related]
5. Identification of predictors for short-term recurrence: comprehensive analysis of 296 retroperitoneal liposarcoma cases.
Yu Z; Li R; Yuan Z; Ye J; He P; Li P; Sun Y; Zhao X
World J Surg Oncol; 2024 Feb; 22(1):46. PubMed ID: 38321480
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of AJCC staging system and proposal of a novel stage grouping system in retroperitoneal liposarcoma: the Fudan Zhongshan experience.
Fan P; Tao P; Wang Z; Wang J; Hou Y; Lu W; Ma L; Zhang Y; Tong H
Front Oncol; 2024; 14():1373762. PubMed ID: 38601763
[TBL] [Abstract][Full Text] [Related]
7. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
Yang M; He H; Peng T; Lu Y; Yu J
Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
[TBL] [Abstract][Full Text] [Related]
8. Identification of biomarkers in laryngeal cancer by weighted gene co-expression network analysis.
Zhang F; She L; Huang D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1136-1151. PubMed ID: 37875354
[TBL] [Abstract][Full Text] [Related]
9. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Wan Q; Tang J; Han Y; Wang D
Exp Eye Res; 2018 Jan; 166():13-20. PubMed ID: 29031853
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Zhou M; Chen Y; Gu X; Wang C
Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
[No Abstract] [Full Text] [Related]
11. Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection.
Luo P; Cai W; Yang L; Chen S; Wu Z; Chen Y; Zhang R; Shi Y; Yan W; Wang C
Cancer Manag Res; 2018; 10():4727-4734. PubMed ID: 30425569
[TBL] [Abstract][Full Text] [Related]
12. Identification of Prognostic Genes in Leiomyosarcoma by Gene Co-Expression Network Analysis.
Yang J; Li C; Zhou J; Liu X; Wang S
Front Genet; 2019; 10():1408. PubMed ID: 32117430
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.
Cui L; Tian X; Yan L; Guan X; Dong B; Zhao M; Lv A; Liu D; Wu J; Hao C
Int J Med Sci; 2022; 19(13):1977-1988. PubMed ID: 36438917
[No Abstract] [Full Text] [Related]
14. The Janus-faced role of TRPM2-S in retroperitoneal liposarcoma via increasing ROS levels.
Li X; Bu F; Ma S; Cananzi F; Zhao Y; Xiao M; Min L; Luo C
Cell Commun Signal; 2022 Aug; 20(1):128. PubMed ID: 36008839
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
[TBL] [Abstract][Full Text] [Related]
16. Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.
Chen PF; Wang F; Nie JY; Feng JR; Liu J; Zhou R; Wang HL; Zhao Q
Onco Targets Ther; 2018; 11():6425-6436. PubMed ID: 30323620
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Immune Landscape of Cirrhosis through Weighted Gene Co-expression Network Analysis.
Zhuoma B; Yang C; Wang W; Ranhen Y
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):168-174. PubMed ID: 37605574
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
Hu X; Sun G; Shi Z; Ni H; Jiang S
PeerJ; 2020; 8():e8505. PubMed ID: 32117620
[TBL] [Abstract][Full Text] [Related]
19. Identification of
Yang H; Wang Y; Zhang Z; Li H
Front Genet; 2020; 11():905. PubMed ID: 32973873
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
